Loading glints...
Congressional Bill H.R. 7148 Signed into Law...
Pacific Biosciences of California (PACB) shifts interim operational duties between CEO and COO effective January 28, 2026 ...
Lam Research Corporation (LRCX) appoints Anirudh Devgan to board and names Seshasayee Varadarajan as COO successor effective March 6, 2026 ...
Advanced Micro Devices (AMD) reports record Q4 revenue of $10.3B and full-year 2025 revenue of $34.6B, driven by strong demand for high-performance computing and AI products. ...
FDA releases annual lists of self-identified generic drug facilities and sites from FY 2014 to FY 2026...
FDA updates NDC Directory with new drug, compounded, and unfinished drug data; no approval implied. ...
Recall of Honey Energy Support contains undeclared tadalafil...
President declares February 2026 as National Black History Month...
Minnesota Democrats blocked deportation of a violent illegal immigrant; Trump administration moves to remove him from the U.S....
FDA issues warning to Kirkman for CGMP violations after 2025 inspection; inadequate change control, process validation, and stability testing identified....
FDA issues warning for Flextronics over CGM manufacturing violations...
FDA issues warning to Carolina Seafood for HACCP violations in seafood dips...
FDA issues warning to quail egg processor for repeated violations of acidified foods regulations and failure to register facility. ...
FDA issues warning to CC Pollen for CGMP violations and misbranding of dietary supplements...
FDA issues warning to Eniva USA for CGMP violations and adulteration of dietary supplements...
FDA issues warning to African food importer for failing to develop and maintain FSVP compliance, risking import bans and detention. ...
FDA issues warning for unapproved nicotine pouch products sold online...
FDA issues warning to Unomedical Device for CGMP violations and unvalidated leak tests on insulin infusion sets. ...
FDA issues warning to Abbott Diabetes Care for CGMP violations in glucose monitoring device manufacturing...
China emphasizes strategic development of future industries with new policies and innovation drives...
FDA releases 2024 Drug Trials Snapshots highlighting demographic participation and trial data for new drug approvals. ...
FDA approves 46 new drugs in 2025 across diverse therapeutic areas including oncology, rare diseases, and cardiovascular conditions. ...
FDA outlines disclosure agreement process for rare disease endpoint development, emphasizing transparency and data protection. ...
FDA issues warning to Eurosirel S.P.A. over CGMP violations including inadequate component testing and quality oversight...
Eurosirel S.P.A. clears FDA warning letter after addressing violations...
FDA updates on drug development tool qualification projects show 151 in progress, 20 qualified, with recent additions across biomarker and clinical outcome programs....
FDA extends GDUFA III reauthorization through September 2027, with new fee structures and electronic payment mandates starting October 2025. ...
FDA updates FY 2025-2026 PDUFA fee rates and payment deadlines; electronic payments now mandatory starting October 1, 2025....
FDA emphasizes safety oversight in human drug compounding amid risks and access concerns...
FDA enhances electronic registration and listing compliance with surveillance, data validation, and enforcement actions including warning letters. ...